RECRUITING

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.

Official Title

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population :A Single-Blinded Randomized Control Trial

Quick Facts

Study Start:2022-11-07
Study Completion:2025-01-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05520593

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Candidates for ambulatory total knee arthroplasty
  2. * Candidates for ambulatory total hip arthroplasty
  3. * Candidates for ambulatory revision knee arthroplasty (liner exchange only)
  4. * Candidates for ambulatory revision hip arthroplasty (liner exchange only)
  5. * Case scheduled before noon (12 pm)
  6. * Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge
  1. * BMI less than 18.5 or greater than 37.0
  2. * Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb.
  3. * Pregnant women
  4. * Patients scheduled as ambulatory due to insurance mandates
  5. * Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate \< 60ml/min.

Contacts and Locations

Study Contact

Jose Rodriguez, MD
CONTACT
212-552-5829
rodriguezjose@hss.edu
Ricardo Torres-Ramirez, BS
CONTACT
212-260-3763
torresr@hss.edu

Principal Investigator

Jose A Rodriguez, MD
PRINCIPAL_INVESTIGATOR
Hospital for Special Surgery, New York

Study Locations (Sites)

Hospital for Special Surgery
New York, New York, 10021
United States

Collaborators and Investigators

Sponsor: Hospital for Special Surgery, New York

  • Jose A Rodriguez, MD, PRINCIPAL_INVESTIGATOR, Hospital for Special Surgery, New York

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-07
Study Completion Date2025-01-24

Study Record Updates

Study Start Date2022-11-07
Study Completion Date2025-01-24

Terms related to this study

Keywords Provided by Researchers

  • Carbohydrate Drink
  • Perioperative Fluids
  • Same-day Discharge
  • Total Joint Arthroplasty
  • Nausea
  • Vomiting
  • Same-day total hip arthroplasty
  • Same-day total knee arthroplasty

Additional Relevant MeSH Terms

  • Same-day Discharge
  • Length of Stay